Member Info for Bushmaster

ColinL1 - Its a good question, its not being discussed on this BB. Personally I don't see it as competitor, simply for the reason price/RRP to the end user or large contracts. Plus its mined, different ball game.

Graphene is the future, anyone who wants to argue that point needs to start researching, and IMO anyone not in Graphene shares is not seeing what is coming. The Graphene masks are a different ball game, its the Bugatti, rather than the Ford - But Graphene is expensive, Graphine Ink is not cheap nor is Graphene itself.

There is a market for both, RMS is much more a mass market product

MJW418, what do you mean 'people don't have any patents'?

MrMerlot, nice 1! The good news is the patent is in, and unlike a lot of members on this BB stating it was all *******s, that puts that to bed. Patent pending, that will go through the system and take a while, but it should stop any other companies from using the same set up.

Sharebel - Nanotechnology and nano particles in cosmetics and dermatology is a new and growing field...Actually!

I am not saying they are not. There are better companies better placed currently to take advantage of what you suggested - I can talk all day about Nano Tech and Graphene, game changers for sure. As I said, to me its a big stretch for RMS to be in what you suggested, not to say they are not either, its all about opinions.

Sharebel, like your thinking but its a bit of stretch for me. DVRG are in the 'skin' make up potential, worth looking at what they are up to. Byotrol are researching seaweed for hand sanitisers, they got a grant so wll be interesting to see how that goes, if that gets the green light it will be good. Sanitisers are causing a lot of issues for a lot of people, so it will be helpful.

hahahehehoho - 'However, without the FDA or CE approvals or mayo link , this would be a pure gamble'

I think that pretty much sums up where we are. If its 5 or 7 on the card so be it, 12/18 months down the road everyone will be happy, even those who paid the top end prices a few weeks back.

bunsenburner123, great post, thanks. Got T but there are so many groups, you could spend all your life on laptop/phone. Need a few contracts, that is what is lacking.

ogm4, udnerstood, thought I had missed something. Looks like its 3 colours, probably black being the killer colour for sale. If you compare this to the two other Graphene masks that are on the market, one is £10, the other is €40ish - although the Italian mask has a lot of USP's, one being it lasts for a year - just change the filter which lasts for 40 hours.

Haydale will distrubute, price from manufacture to them, so there is one margin (maybe they have a deal in place for a better margin due to the business relationship) Then Haydale should have a few price lists - Distrubution (say 50,000) and then wholesale - in the hundreds. In betweem that might be contract prices, ie: NHS, all bespoked pricing structures.

Take it as a given they have this in place? or what classifications? - https://ec.europa.eu/health/sites/health/files/md_sector/docs/md_guidance-reg-req-med-face-masks.pdf

The average RRP of mask in the UK is £5 (seems what most brands/online stores average at)

How will the mask be marketed, what are the USPS - What is the POS/packaging like if they want to knock on Boots door - That will determine how far up the RRP can go - Personally, anything under £5 will hit everyone, once you start crossing the £7/£8 line (unless the marketing is the dogs nuts) then sales will drop off significantly.

Derek Yoon, iCraft, General Manager - Are they going to support a marketing budget in the UK, Europe?

From the RNS - It has been proven to maintain these properties for up to 10 washes.

What is it, 10 or 5 - lets hope the packaging/marketing message is a bit more cleverer than that line. I take a guess, which is the KEY KEY point - How long does it last for, " the antibacterial activity of 99.9%" Do you wash the mask daily (presume it depends on your job) and the 99% antibacterial activity runs out? Point I am making, these are basic questions any buyer will ask them, and for Haydale they need to be precise - You don't want someone catching CV19 and its blamed on the mask because the marketing message is so broad.

Lets say its 5 washes to be safe to be 99.9% effective - Once a day its washed (recommended) that is 40 hours per week (call it 7 days/1 week) For mass sales, serious volumne, RRP is £5 - cost per day use for the end user is 71 pence per day (7 day use + that is constant use/40 hours plus)

Nothing to say Haydales margin cannot be a £1 + - PR/Marketing budget is key if they wholeale.

ogm4, have you any indication on a cost or RRP?

Can I ask where you are getting packs of 20 masks from?

Afternoon all, I think Graphene has a very bright future, over the coming months/years the market will adapt Graphene in a huge way. There are only a handful of companies, you can see the SP on those, two had decent RNS out and both have risen and held up well. The amount of product that Graphene can be used in is insane/I am not even thinking about the medical sector. Terrible as CV19 is, its open the doors for a lot more RnD/funding and in term will get a lot more limelight, which will push the whole industry into peoples mindset. The Graphene ink is going to be a big game changer. GLA

Good news. SP going in the right direction. Be good to put some meat on the bones and know what the sale targets are.

This is an interesting article, good overall information with a few diagrams. It has several links. The Chinese links are worth a read, discussing this issue back in 2002/3. Be interesting to know if GB is talking to these contributors/in ref to doing business in China.

Humanity has experienced outbreaks by viruses such as severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) in 2003, Eastern respiratory syndrome coronavirus (MERS-CoV) in 2012, Ebola virus in 2014 and nowadays SARS-CoV-2.....

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522648/

Lottohopes, top find mate.

mararab, great me too. A couple more companies worth looking at as well. Haydale, when that goes North its going to be a very good share to have, but 100% with you, the SP is like a snail - On the plus side it can't go backwards :) The Thai military contract looks interesting.

mararab, great me too. A couple more companies worth looking at as well. Haydale, when that goes North its going to be a very good share to have, but 100% with you, the SP is like a snail - On the plus side it can't go backwards :) The Thai military contract looks interesting.

mararab, the ink is the key. This is the whole Graphene market, the next big big big explosion for retail/manufacturing use. Over the next 3/6/24 months nanaotech along with Graphene/which IMO is where this all heading in regards to killing virus, bacteria etc. The SA army have been using some tech for a while/back in the day when I did my stint clothing in the bush/temp/ripping etc was a major issue - Graphene is 200 times stronger than steel, light as a feather, has antibacterial features. There is a UK company who has Graphene ink, contracted from a Canadian company who own the patent, think what you can do with that! They have just got this into leather - top end car brands, USP is - Leather kills viruses, CV 19 included. Billabong have a Graphene wetsuit, game changer not just for surfing, diving etc.

Imagine a plaster, goes onto your arm, this plaster can tell you if you have medical issues - no injections - This is where nanoteach is going, RMS IMO will be a part of this industry.

This NHS addiction contract is IMO just crazy. PP, for ward use/ops you are more than likely right with the information we currently have - That is not to say a V2 or V3 of the mask is not being work on, I don't believe that part is rocket science as the hard graft of tech has been completed.

In the rest of the NHS you still have everyone else, cooks, cleaners, reception staff etc etc...so there is a market.

Park all that - From what we know there is one machine on its way, but there could be 2/3, we have no idea. Then we have Volz, I am pretty sure, 99.99% confident they will not rely on the UK machine (s) and are working on a plan to be self sufficient.

The UK - Why even go to the NHS on a limit of 5/10/15 mill a month? There are numerous other markets to go into, which will have a better return/ROI for RMS - The private medical sector/care homes would swallow that amount on easily - Factories, manufacturing/sports event etc...the list is endless. When you are limited on supply, you don't need contracts like the NHS, the profit margins are reduced, so why would they chase contracts such as those, unless they had the capacity to produce.

I would think, as memtioned various other versions of this mask are being worked on, if not approved and ready to roll out, with a complete different pricing structure.

Interesting to see the direction this is going - A contract with a major car brand, Merc/RR will really highlight the company, as well as some great press for the car brands. They can do the production numbers to compete with exising suppliers of leather, a great USP for a car brand.

Hopefully the front page of the new site will have images of their machines being revamped for the new tech mask - along with a cracking video showing the masks being popped out like smarties...A lot of people concentrating on the machine (s) arriving from Spain into the UK, but Volz have mask machines - Germany engineering, say no more. A few screws here (you get the point) and off they go - Licencing a few weeks back was a big conversational point on this BB.

One thing is for sure, news is coming and I think it will be mulit faceted, with a nice cherry on top with USA licencing agreement to see us through the box of Roses on Christmas day.

havealot, I am not sure up to this point UK Gov is that concerned on the LFT accuracy, Innova are Chinese, pretty much tells you how BJ hands are tied - The big issue being UK diagnostics had no production/product. With Omega production in place and up and running, MHRA approval for self-test use of the AbC-19™ Rapid test expected following final usability study, the scenery is about to change. I